JP Morgan resumed coverage on PACS Group with a new price target
$PACS
Hospital/Nursing Management
Health Care
JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2024 | $18.00 | Overweight → Neutral | Analyst |
| 11/6/2024 | $40.00 | Overweight | JP Morgan |
| 10/9/2024 | $50.00 | Buy | UBS |
| 9/11/2024 | $45.00 | Buy | Citigroup |
| 6/28/2024 | $35.00 | Outperform | Macquarie |
4 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
4 - PACS Group, Inc. (0002001184) (Issuer)
8-K - PACS Group, Inc. (0002001184) (Filer)
8-K - PACS Group, Inc. (0002001184) (Filer)
NT 10-Q - PACS Group, Inc. (0002001184) (Filer)
Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00
JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00
UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00
Believes NHC faces three potential outcomes with the NHI lease renewal – all of which could lead to a significant decline in NHC earnings and likely material share price weakness NHC may lose 19% to 38% of EBITDA with substantial downside and reputational risk if the company overplays its hand Believes recent developments put NHI in catbird seat in renegotiation and company could see a 12% increase in annual FFO/share when rents are marked to market with potentially more upside if released to a best-in-class operator Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings") issued the following statement: "National Healthcare Corporation's
Audit Committee Investigation Substantially Complete PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that it will restate its previously issued condensed combined/consolidated financial statements as of and for the three months ended on March 31, 2024 included in the Company's Quarterly Report on Form 10-Q filed with the SEC on May 13, 2024 (as amended on May 21, 2024), and as of and for the three and six months ended on June 30, 2024 included in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 12, 2024 (collectively, the "Prior Financial Statements," and each such quarterly period in the six months ended June 30, 2024, the "Impacted Periods"
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that independent operating subsidiaries of the Company closed on the operations of 11 skilled nursing facilities in Tennessee on December 1, 2024, which collectively comprise 1,310 skilled nursing beds; a 12th facility in Tennessee is expected to close in the first quarter of 2025, subject to the satisfaction of applicable closing conditions. With the expansion into Tennessee, PACS has now acquired a total of 38 facilities since October 31, 2024, adding 4,700 skilled nursing beds to its portfolio. "We're excited to close these latest acquisitions, which further expand PACS' footprint to 17 states, bringing our services